Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Third Quarter 2015 Earnings Conference Call

WEST LAFAYETTE, Ind., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Tuesday, Nov. 3rd, at 4:30 p.m. EST to discuss its...
September 21, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present Data on EC1456 at the European Cancer Congress 2015

WEST LAFAYETTE, Ind., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
September 07, 2015 14:45 ET | Source: Endocyte, Inc.

Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients

WEST LAFAYETTE, Ind., Sept. 7, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), today presented the final overall survival (OS) analysis from the Phase 2b TARGET trial evaluating its small...
September 03, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at Upcoming Healthcare Conferences

WEST LAFAYETTE, Ind., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
August 12, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Presentations at the 250th American Chemical Society National Meeting & Exposition

WEST LAFAYETTE, Ind., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a bio-pharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and...
August 04, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte Reports Second Quarter 2015 Financial Results and Provides Update on Clinical Progress

- Dose Escalation for EC1456 and EC1169 Advance in Phase 1 Studies - - Final Overall Survival Analysis From TARGET Trial of EC145 in NSCLC to be Presented at the World Conference on Lung Cancer...
August 04, 2015 07:30 ET | Source: Endocyte, Inc.

Endocyte Appoints Dr. Alison A. Armour as Chief Medical Officer

WEST LAFAYETTE, Ind., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
August 03, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at the 2015 Wedbush PacGrow Healthcare Conference

WEST LAFAYETTE, Ind., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
July 28, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte Announces Second Quarter 2015 Earnings Conference Call

WEST LAFAYETTE, Ind., July 28, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Tuesday, Aug. 4th, at 4:30 p.m. EDT to discuss its...
July 01, 2015 16:01 ET | Source: Endocyte, Inc.

Endocyte to Present at the Cantor Fitzgerald Healthcare Conference

WEST LAFAYETTE, Ind., July 1, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...